This contract expires in 111 days (Sep 30, 2026).

Browse related active opportunities

FIRM FIXED PRICE

ACTELION PHARMACEUTICALS US, INC. - UPTRAVI 800MCG TABS

PIID: 36C26026F0017
Signed Date: Oct 1, 2025Effective Date: Oct 1, 2025End Date: Closes in 111 days
Award $
$407K
Vendor
ACTELION PHARMACEUTICALS US, INC.
NAICS
325412
Signed Date
Oct 1, 2025

Key Details

Dollars Obligated
$406,537.68
Base & All Options
$406,537.68
Awarding Sub-Agency
Department of Veterans Affairs
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
1
Place of Performance
MEMPHIS, TN, 381348822, CD-TN-08

Description

UPTRAVI 800MCG TABS

Context & Analysis

On Oct 1, 2025, Department of Veterans Affairs obligated $406,537.68 to ACTELION PHARMACEUTICALS US, INC. for uptravi 800mcg tabs. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in MEMPHIS, TN. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining.

Contractor Information

UEI: H5BMHLMMNA28
CAGE Code: 33TN9
Location: TITUSVILLE, NJ

Stay Updated

Get notified about new opportunities matching your interests.

Related